We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+23.69%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$6.79B
AUM Growth
+$377M
Cap. Flow
-$743M
Cap. Flow %
-10.93%
Top 10 Hldgs %
13.56%
Holding
361
New
33
Increased
100
Reduced
180
Closed
46

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$50.8M
2
DRI icon
Darden Restaurants
DRI
+$42M
3
PH icon
Parker-Hannifin
PH
+$41M
4
COR icon
Cencora
COR
+$26.6M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$25.7M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$56M
2
T icon
AT&T
T
+$48.7M
3
GILD icon
Gilead Sciences
GILD
+$48.6M
4
QDEL icon
QuidelOrtho
QDEL
+$36.3M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$32.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Financials 15.82%
3 Technology 13.99%
4 Industrials 13.07%
5 Consumer Discretionary 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$116M 1.7%
568,535
-49,197
-8% -$8.93M
JPM icon
2
JPMorgan Chase
JPM
$935B
$113M 1.66%
1,198,468
-123,624
-9% -$11.7M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$99.7M 1.47%
1,405,460
+265,680
+23% +$17.9M
VZ icon
4
Verizon
VZ
$195B
$99.4M 1.46%
1,803,106
-185,739
-9% -$10.4M
AAPL icon
5
Apple
AAPL
$4.54T
$99.3M 1.46%
1,088,400
-94,072
-8% -$7.29M
BAC icon
6
Bank of America
BAC
$435B
$96.3M 1.42%
4,054,931
-250,220
-6% -$5.91M
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$82.3M 1.21%
585,132
+38,280
+7% +$5.58M
MDT icon
8
Medtronic
MDT
$109B
$75.1M 1.11%
819,281
-82,900
-9% -$7.95M
AMZN icon
9
Amazon
AMZN
$2.92T
$70.3M 1.04%
509,780
-80,900
-14% -$9.77M
PWR icon
10
Quanta Services
PWR
$100B
$70.3M 1.03%
1,791,047
-249,206
-12% -$8.89M
CVX icon
11
Chevron
CVX
$392B
$66.2M 0.98%
742,386
+105,782
+17% +$9.47M
PG icon
12
Procter & Gamble
PG
$336B
$65.7M 0.97%
549,426
-479,795
-47% -$56M
TMO icon
13
Thermo Fisher Scientific
TMO
$213B
$64.1M 0.94%
177,002
-17,552
-9% -$5.88M
MRK icon
14
Merck
MRK
$322B
$57.1M 0.84%
774,388
-76,724
-9% -$5.78M
DTE icon
15
DTE Energy
DTE
$29.5B
$56.7M 0.83%
619,230
-63,805
-9% -$5.65M
ABBV icon
16
AbbVie
ABBV
$443B
$56.6M 0.83%
+576,811
New +$50.8M
LLY icon
17
Eli Lilly
LLY
$1.02T
$56.3M 0.83%
342,946
-34,299
-9% -$5.26M
KMB icon
18
Kimberly-Clark
KMB
$36.3B
$56M 0.83%
396,486
-56,884
-13% -$7.85M
WTW icon
19
Willis Towers Watson
WTW
$31.2B
$55.6M 0.82%
282,275
-26,955
-9% -$5.16M
CMCSA icon
20
Comcast
CMCSA
$85B
$54.2M 0.8%
1,389,808
-618,420
-31% -$23.6M
TGT icon
21
Target
TGT
$65.6B
$53.3M 0.78%
444,145
-43,426
-9% -$4.96M
STT icon
22
State Street
STT
$50.6B
$52.7M 0.78%
829,009
+209,227
+34% +$12.6M
DUK icon
23
Duke Energy
DUK
$97.8B
$52M 0.77%
650,625
-66,441
-9% -$5.61M
DIS icon
24
Walt Disney
DIS
$167B
$51.5M 0.76%
462,024
+157,639
+52% +$17.4M
MDLZ icon
25
Mondelez International
MDLZ
$79.5B
$50.9M 0.75%
996,251
-98,475
-9% -$5.06M
1
2 3 4 5

Similar funds

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Rothschild & Co Asset Management US's Q2 2020 Portfolio in Review

As of Q2 2020, Rothschild & Co Asset Management US held 361 positions worth $6.79B, up 5.9% from $6.41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Rothschild & Co Asset Management US withdrew a net $743M in Q2 2020, closing 46 positions and reducing 180 holdings. Its most notable exit was Gilead Sciences, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Rothschild & Co Asset Management US opened a new position in AbbVie worth $56.6M.

  • Rothschild & Co Asset Management US's largest Q2 2020 buy was AbbVie: 576,811 shares worth $56.6M.
  • Rothschild & Co Asset Management US added most to Parker-Hannifin in Q2 2020, an estimated $41M increase.
  • Rothschild & Co Asset Management US's biggest Q2 2020 reduction was Procter & Gamble, cutting an estimated $56M.
  • Rothschild & Co Asset Management US fully exited Gilead Sciences in Q2 2020, selling an estimated $48.6M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $6.79B portfolio in Q2 2020.
  • Rothschild & Co Asset Management US opened 33 new positions and closed 46 in Q2 2020.
  • Rothschild & Co Asset Management US's portfolio value rose 5.9% quarter-over-quarter to $6.79B.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.